Invesco Biotechnology & Genome ETF
PBE
#1989
ETF Rang
€0.22 Mrd.
Marktkapitalisierung
🇺🇸 US
Markt
70,13 €
Aktienkurs
-1.23%
Veränderung (1 Tag)
10.41%
Veränderung (1 Jahr)
Kategorien

Invesco Biotechnology & Genome ETF - Bestände

ETF-Bestände zum Stand 28. Dezember 2025

Anzahl der Bestände: 32

Vollständige Bestandsliste

Gewichtung %NameTickerGehaltene Aktien
5.18%Illumina IncILMN101321
5.13%United Therapeutics CorpUTHR26744
4.98%Regeneron Pharmaceuticals IncREGN16760
4.84%Gilead Sciences IncGILD101879
4.84%Biogen IncBIIB72177
4.81%Amgen IncAMGN38176
4.55%Incyte CorpINCY120128
4.46%Alnylam Pharmaceuticals IncALNY29390
3.80%Amicus Therapeutics IncFOLD703874
3.54%Dynavax Technologies CorpDVAX608506
3.05%ACADIA Pharmaceuticals IncACAD291268
2.97%MannKind CorpMNKD1356982
2.94%BioCryst Pharmaceuticals IncBCRX1019226
2.88%Exelixis IncEXEL164764
2.88%Collegium Pharmaceutical IncCOLL152744
2.85%BioMarin Pharmaceutical IncBMRN125429
2.73%Catalyst Pharmaceuticals IncCPRX296100
2.71%Neurocrine Biosciences IncNBIX49283
2.68%Madrigal Pharmaceuticals IncMDGL11840
2.68%Ionis Pharmaceuticals IncIONS88656
2.67%Protagonist Therapeutics IncPTGX79385
2.62%Repligen CorpRGEN41619
2.60%Royalty Pharma PLCRPRX175127
2.59%PTC Therapeutics IncPTCT87201
2.55%Vericel CorpVCEL179046
2.53%QIAGEN NVQGEN147423.1353
2.53%TG Therapeutics IncTGTX217337
2.46%Bio-Techne CorpTECH109644
2.45%Halozyme Therapeutics IncHALO94071
2.40%Veracyte IncVCYT149064
0.08%Invesco Government & Agency PortfolioAGPXX202783.89
0.00%CASH & EQUIVALENTSUSD4654.67